ACHV - Achieve Life Sciences announces proposed public offering; shares down nearly 13%
2025-06-26 16:12:52 ET
More on Achieve Life Sciences
- Achieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies Risk
- Achieve Life Sciences, Inc. (ACHV) Q1 2025 Earnings Call Transcript
- Achieve Life Sciences targets NDA submission for cytisinicline in June 2025 as open label study hits key milestones
- Seeking Alpha’s Quant Rating on Achieve Life Sciences
- Historical earnings data for Achieve Life Sciences